Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
52 items
Photo shows T. Michael Redmond, Ph.D.

NIH vision researcher T. Michael Redmond recognized with Champalimaud Vision Award

Vision researcher, T. Michael Redmond, Ph.D., chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, is a recipient of the 2018 António Champalimaud Vision Award for foundational science discoveries about the molecular
James Golladay and Aman George hold up grant award check

Knights Templar Eye Foundation awards research grant to NEI scientist

National Eye Institute (NEI) Postdoctoral Fellow Aman George, Ph.D., has received a $65,000 grant from the Knights Templar Eye Foundation to identify new drug treatments for vision impairment in children with a type of albinism.
Retina organoids mimic the structure and function of the human retina to serve as a platform to study underlying causes of retinal diseases, test new drug therapies, and provide a source of cells for transplantation. credit: David Gamm, M.D., Ph.D., University of Wisconsin-Madison

NIH solicits next-generation retina organoids in prize competition

A competition for radical ideas in the fight against blindness will move to its next phase by challenging participants to build functioning human retina prototypes.
Aqueous humor flows out of the anterior chamber through the open angle where the cornea meets the iris. The open angle consists of two routes: the conventional, trabecular pathway, which includes a spongy layer called the trabecular meshwork, and the non-conventional, uveoscleral pathway, through the ciliary muscle that controls the eye’s focusing mechanism. The majority of fluid flows out via the trabecular pathway, which acts like a one-way valve. About a third of the fluid exits through the uveoscleral p

NEI support paved early pathway for novel glaucoma therapies

The recent approval of two novel medications for glaucoma – the first new medications for the disorder in nearly 18 years – are fruit borne from decades of foundational scientific research supported by the National Eye Institute (NEI).
anniversary logo

Fifty years of vision research opens window into the brain

The eye is more than a window to the soul; it is a window to the brain.
chart

National Eye Institute awards prize for ‘Retina in a dish’ competition

A proposal to create a living model of the human retina, the light-sensitive tissue at the back of the eye, won $90,000 in the National Eye Institute (NEI) 3-D Retina Organoid Challenge (3-D ROC).
blueprint eye

NIH launches competition to develop human eye tissue in a dish

The National Eye Institute (NEI), part of the National Institutes of Health, has opened the first stage of a federal prize competition designed to generate miniature, lab-grown human retinas.
Young boy gets eye exam.

Statement by NEI Director Paul A. Sieving, M.D., Ph.D., on National Academies’ report outlining public health strategies to promote and protect healthy vision for all Americans

Today, the National Academies of Sciences, Engineering, and Medicine (the National Academies) released “Making Eye Health A Population Health Imperative: Vision for Tomorrow.
Artist’s rendering of neural activity in the retina. Light that enters the eye activates rod and cone photoreceptors, which then activates retinal ganglion cells. A signal travels to the brain via the retinal ganglion cell axons. Photo credit: National Eye Institute

Six teams seek to identify biological factors that influence neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.
James W. Gollady, Jr., Right Eminent Department Commander (right), presents Hotaling with a check from the Knights Templar Eye Foundation. “I think this award is extremely important to pave a pathway for me in medical research,” said Hotaling. (Joe Balintfy, NEI)

NEI Scientist Receives Research Grant from Knights Templar Eye Foundation

NEI research fellow Nathan Hotaling, PhD, has been awarded a $65,000 grant from the Knights Templar Eye Foundation to develop a stem cell-based system to study Best disease, a genetic disorder that can cause progressive vision loss.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248